HK166295A - Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus - Google Patents
Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virusInfo
- Publication number
- HK166295A HK166295A HK166295A HK166295A HK166295A HK 166295 A HK166295 A HK 166295A HK 166295 A HK166295 A HK 166295A HK 166295 A HK166295 A HK 166295A HK 166295 A HK166295 A HK 166295A
- Authority
- HK
- Hong Kong
- Prior art keywords
- glycoproteins
- respiratory syncytial
- syncytial virus
- human respiratory
- chimeric
- Prior art date
Links
- 102000003886 Glycoproteins Human genes 0.000 title abstract 5
- 108090000288 Glycoproteins Proteins 0.000 title abstract 5
- 241000711920 Human orthopneumovirus Species 0.000 title abstract 2
- 230000002163 immunogen Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 238000011081 inoculation Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13738787A | 1987-12-23 | 1987-12-23 | |
| PCT/US1988/003784 WO1989005823A1 (en) | 1987-12-23 | 1988-10-31 | Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK166295A true HK166295A (en) | 1995-11-03 |
Family
ID=22477194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK166295A HK166295A (en) | 1987-12-23 | 1995-10-26 | Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US5194595A (fi) |
| EP (1) | EP0396563B1 (fi) |
| JP (1) | JP2716503B2 (fi) |
| KR (1) | KR0137963B1 (fi) |
| AT (1) | ATE85622T1 (fi) |
| AU (1) | AU617739B2 (fi) |
| CA (1) | CA1320163C (fi) |
| DE (1) | DE3878468T2 (fi) |
| DK (1) | DK173175B1 (fi) |
| FI (1) | FI102382B1 (fi) |
| HK (1) | HK166295A (fi) |
| MX (1) | MX9203458A (fi) |
| NO (1) | NO300254B1 (fi) |
| WO (1) | WO1989005823A1 (fi) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8914968D0 (en) * | 1989-06-29 | 1989-08-23 | Connaught Lab | Production of virus and purification of viral envelope proteins for vaccine use |
| US6004563A (en) * | 1990-11-07 | 1999-12-21 | American Home Products Corporation | Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same |
| US5824307A (en) | 1991-12-23 | 1998-10-20 | Medimmune, Inc. | Human-murine chimeric antibodies against respiratory syncytial virus |
| GB9200117D0 (en) * | 1992-01-06 | 1992-02-26 | Connaught Lab | Production of recombinant chimeric proteins for vaccine use |
| GB9207479D0 (en) * | 1992-04-06 | 1992-05-20 | Scotgen Ltd | Novel antibodies for treatment and prevention of respiratory syncytial virus infection in animals and man |
| TW275632B (fi) * | 1992-04-21 | 1996-05-11 | American Cyanamid Co | |
| KR960700271A (ko) * | 1993-01-08 | 1996-01-19 | 로렌스 티. 웰츠 | 인간 호흡계 합포체 바이러스 fg 당단백질의 정제 및 리폴딩 방법(process for the purification and refolding of human respiratory syncytial virus fg glycoprotein) |
| JP3734263B2 (ja) * | 1993-05-25 | 2006-01-11 | ワイス・ホールディングズ・コーポレイション | 呼吸器シンシチウムウイルスに対するワクチンのためのアジュバント |
| US7300918B2 (en) | 1994-01-14 | 2007-11-27 | Matthias Rath | Method of producing vaccines from protein signal oligopeptides |
| DE69534077T2 (de) * | 1994-01-14 | 2005-08-11 | Rath, Matthias, Dr.med. | Verwendung von methoden zur identifizierung von hydrophilen signal-oligopeptiden |
| FR2718452B1 (fr) * | 1994-04-06 | 1996-06-28 | Pf Medicament | Elément d'immunogène, agent immunogène, composition pharmaceutique et procédé de préparation. |
| US5716821A (en) * | 1994-09-30 | 1998-02-10 | Uab Research Foundation | Prevention and treatment of respiratory tract disease |
| US5789229A (en) * | 1994-09-30 | 1998-08-04 | Uab Research Foundation | Stranded RNA virus particles |
| FR2726472B1 (fr) * | 1994-11-07 | 1997-01-31 | Pf Medicament | Proteine porteuse a effet adjuvant, complexe immunogene la contenant, leur procede de preparation, sequence nucleotidique et vaccin |
| DE4442114A1 (de) * | 1994-11-25 | 1996-05-30 | Buna Sow Leuna Olefinverb Gmbh | Nitrit-, phosphat- und aminfreies Kühl- und Wärmeübertragungsmittel |
| US5811524A (en) * | 1995-06-07 | 1998-09-22 | Idec Pharmaceuticals Corporation | Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof |
| US6015664A (en) * | 1995-11-03 | 2000-01-18 | Mcw Research Foundation | Multiplex PCR assay using unequal primer concentrations to detect HPIV 1,2,3 and RSV A,B and influenza virus A, B |
| WO1998018819A1 (en) * | 1996-10-29 | 1998-05-07 | Smithkline Beecham Biologicals S.A. | Purification of respiratory syncytial virus antigens |
| US20070067859A1 (en) * | 1997-07-14 | 2007-03-22 | Michel Georges | Double-muscling in mammals |
| DK2045322T3 (en) * | 1997-07-14 | 2015-10-05 | Université de Liège | DOUBLE MUSCULAR FOR MAMMALS |
| US6103466A (en) * | 1997-07-14 | 2000-08-15 | University Of Liege | Double-muscling in mammals |
| US6699478B1 (en) * | 1997-09-19 | 2004-03-02 | Wyeth Holdings Corporation | Enhanced immune response to attachment (G) protein of Respiratory Syncytial Virus |
| GB9909077D0 (en) | 1999-04-20 | 1999-06-16 | Smithkline Beecham Biolog | Novel compositions |
| CA2398466A1 (en) * | 2000-01-27 | 2001-08-02 | Medimmune, Inc. | Ultra high affinity neutralizing antibodies |
| EP2341074A1 (en) * | 2000-03-01 | 2011-07-06 | MedImmune, LLC | Antibodies binding to the f protein of a respiratory syncytial virus (rsv) |
| US7179900B2 (en) * | 2000-11-28 | 2007-02-20 | Medimmune, Inc. | Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
| US6855493B2 (en) | 2000-11-28 | 2005-02-15 | Medimmune, Inc. | Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
| US7132100B2 (en) | 2002-06-14 | 2006-11-07 | Medimmune, Inc. | Stabilized liquid anti-RSV antibody formulations |
| DE602005018473D1 (de) * | 2004-05-24 | 2010-02-04 | Polymun Scient Immunbio Forsch | Superbeladene liposome für die arzneimittelabgabe |
| JP2008518936A (ja) * | 2004-10-29 | 2008-06-05 | メディミューン，インコーポレーテッド | Ｒｓｖ感染症および関連状態を予防および治療する方法 |
| EP1997830A1 (en) | 2007-06-01 | 2008-12-03 | AIMM Therapeutics B.V. | RSV specific binding molecules and means for producing them |
| EP3508505A1 (en) | 2007-12-24 | 2019-07-10 | ID Biomedical Corporation of Quebec | Recombinant rsv antigens |
| EP2324062A4 (en) * | 2008-07-18 | 2012-06-06 | Id Biomedical Corp Quebec | CHIMERIC RSV POLYPEPTIDE ANTIGEN |
| PE20121541A1 (es) | 2009-06-24 | 2012-12-21 | Glaxosmithkline Biolog Sa | Antigenos de virus de sincicio respiratorio recombinantes |
| SG178026A1 (en) | 2009-07-15 | 2012-03-29 | Novartis Ag | Rsv f protein compositions and methods for making same |
| US8568726B2 (en) | 2009-10-06 | 2013-10-29 | Medimmune Limited | RSV specific binding molecule |
| CA2879915C (en) | 2012-08-01 | 2022-07-05 | Bavarian Nordic A/S | Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4855224A (en) * | 1984-03-09 | 1989-08-08 | Genentech, Inc. | Molecularly cloned diagnostic product and method of use |
| DE3689622T2 (de) * | 1986-01-14 | 1994-06-16 | Univ North Carolina | Impfstoffe gegen menschliche respiratorische viren. |
| US5223254A (en) * | 1987-09-29 | 1993-06-29 | Praxis Biologics, Inc. | Respiratory syncytial virus: vaccines |
| US5001230A (en) * | 1988-02-18 | 1991-03-19 | Schering Corporation | T cell activation markers |
| SG106639A1 (en) * | 2000-10-10 | 2004-10-29 | Gen Electric | Apparatus and method for introducing small amounts of refractory elements into a vapor deposition coating |
-
1988
- 1988-10-31 DE DE8888909879T patent/DE3878468T2/de not_active Expired - Lifetime
- 1988-10-31 EP EP88909879A patent/EP0396563B1/en not_active Expired - Lifetime
- 1988-10-31 AU AU27850/89A patent/AU617739B2/en not_active Expired
- 1988-10-31 MX MX9203458A patent/MX9203458A/es unknown
- 1988-10-31 WO PCT/US1988/003784 patent/WO1989005823A1/en active IP Right Grant
- 1988-10-31 JP JP63509171A patent/JP2716503B2/ja not_active Expired - Lifetime
- 1988-10-31 AT AT88909879T patent/ATE85622T1/de not_active IP Right Cessation
- 1988-10-31 US US07/543,780 patent/US5194595A/en not_active Expired - Lifetime
- 1988-10-31 KR KR1019890701589A patent/KR0137963B1/ko not_active IP Right Cessation
- 1988-11-07 CA CA000582378A patent/CA1320163C/en not_active Expired - Lifetime
-
1990
- 1990-06-21 FI FI903154A patent/FI102382B1/fi not_active IP Right Cessation
- 1990-06-22 NO NO902802A patent/NO300254B1/no not_active IP Right Cessation
- 1990-06-22 DK DK199001532A patent/DK173175B1/da not_active IP Right Cessation
-
1992
- 1992-11-20 US US07/979,505 patent/US5288630A/en not_active Expired - Lifetime
-
1995
- 1995-10-26 HK HK166295A patent/HK166295A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2716503B2 (ja) | 1998-02-18 |
| DE3878468D1 (de) | 1993-03-25 |
| NO902802L (no) | 1990-06-22 |
| AU2785089A (en) | 1989-07-19 |
| EP0396563B1 (en) | 1993-02-10 |
| NO902802D0 (no) | 1990-06-22 |
| ATE85622T1 (de) | 1993-02-15 |
| FI102382B (fi) | 1998-11-30 |
| DK153290A (da) | 1990-08-16 |
| FI903154A0 (fi) | 1990-06-21 |
| US5194595A (en) | 1993-03-16 |
| DK173175B1 (da) | 2000-03-06 |
| CA1320163C (en) | 1993-07-13 |
| DK153290D0 (da) | 1990-06-22 |
| JPH03501723A (ja) | 1991-04-18 |
| KR900700508A (ko) | 1990-08-13 |
| AU617739B2 (en) | 1991-12-05 |
| KR0137963B1 (ko) | 1998-04-30 |
| EP0396563A1 (en) | 1990-11-14 |
| FI102382B1 (fi) | 1998-11-30 |
| MX9203458A (es) | 1992-09-01 |
| NO300254B1 (no) | 1997-05-05 |
| US5288630A (en) | 1994-02-22 |
| DE3878468T2 (de) | 1993-06-09 |
| WO1989005823A1 (en) | 1989-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK166295A (en) | Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus | |
| KR970009347B1 (en) | Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3 | |
| DE3856141D1 (en) | Respiratorisches syncytiales virus, impstoffe | |
| EP0855918A4 (en) | INTERLEUKIN-15 FROM CHICKEN AND USES THEREOF | |
| EE9900343A (et) | Sünteetiline polünukleotiid, immuunvastuste tekitamise meetod, immunogeenne kompositsioon, anti-HIV immuunvastuste indutseerimise meetod, meetod antigeeni tekitava raku indutseerimiseks ja farmatseutiline kompositsioon | |
| ES500567A0 (es) | Procedimiento de preparar complejos vacunantes por reaccion de arn ribonosales y de antigenos especificos. | |
| FI101632B1 (fi) | Menetelmä Bordetella pertussis-toksiinin alayksikön analogien valmistamiseksi ja niitä koodaavia rekombinantti-DNA-molekyylejä | |
| HK51597A (en) | Vaccines for human respiratory virus | |
| ZA918876B (en) | Avirulent microbes and uses therefor:salmonella typhi | |
| ATE73349T1 (de) | Hepatitisoberflaechenantigenpartikelvakzin. | |
| MY101874A (en) | Vaccine | |
| EP0186368A3 (en) | Biological preparations |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PF | Patent in force | ||
| PE | Patent expired |
Effective date: 20081030 |